… patent dispute with Bayer over the pharmaceutical rivaroxaban, which paved the way for the launch of its generic product in the UK market. Phillip …
… patent dispute with Bayer over the pharmaceutical rivaroxaban, which paved the way for the launch of its generic product in the UK market. Phillip …